Sun Pharma receives USFDA nod for anti-cholesterol drug

"As per IMS, ezetimibe tablets had annual sales of approximately USD 2.7 billion in the US for the 12 months ended April 2017," it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news